GeneCust offers an improved technology to simplify and accelerate the construction of adenoviral vectors, which offer many advantages to investigators who study gene expression or gene silencing in mammalian systems. Adenoviruses have a strong safety record and recombinant adenoviral vectors have been useful tools for gene function studies as well as for human gene therapy. Recombinant adenoviruses that cannot replicate are attractive vectors for gene delivery for several reasons:
GeneCust has been providing the high quality services and technical supports to researchers in academic institutes, pharmaceutical and biotech industrials since 2002. Currently, GeneCust is providing a complete line of adenoviral services.
Lentiviral and Retroviral services
Delivery of genes by lentivirus has been well established and is currently widely used due to several advantages: Lentiviruses can accommodate long sequences and seem to be non-immunogenic due to the lack of viral coding sequences transfer; the lentiviruses are able to transduce non-dividing cells; and the products can be stably expressed due to integration into the cell chromosome.
GeneCust provides the lentiviral and retroviral services for research applications.
Adeno-associated Virus Services
Adeno-associated virus (AAV) vectors are currently among the most frequently used viral vectors for gene therapy. AAV is an ideal virus to use as the vehicle for gene transfer because: